Brar says RapidAnalyzer™ helps execute large volumes of analytical workflows
Excelra, with offices in Hyderabad, Boston and Utrecht (the Netherlands), has made a strategic majority investment in Boston-headquartered Anlitiks, as its commitment to drug discovery and commercialization by combining deep scientific domain expertize with cutting-edge technology and analytics solutions.
The investment reinforces Excelra’s push into the Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) analytics area.
Anlitiks is a HEOR and RWE company, founded by Kannan Rajagopalan, a technology entrepreneur and a mission to help Life Sciences organizations translate real-world data rapidly into value evidence, using a unique data + platform + service approach.
The engine driving the business is Anlitiks’ RapidAnalyzer™, a flexible, data-agnostic platform that captures the entire lifecycle of HEOR/RWE from hypothesis, data integration, analysis, visualization to a research report.
RapidAnalyzer™ changes the competitive landscape by drastically reducing the time taken to gain valuable insights on large-scale data from months to just a matter of weeks.
Anandbir Brar, Chief Executive Officer at Excelra, underlined on 20 Apr 2022, “Anlitiks has a unique platform plus consulting business model, combining highly skilled and experienced HEOR experts, and an integrated platform – RapidAnalyzer™ that helps execute large volumes of analytical workflows.
“Our combined strength empowers Life Science organizations with accelerated yet informed decision-making.”
Data and Digital transformation have become a strategic imperative for the Life Sciences industry to break down silos between multi-omics, clinical trials, and real-world data. The partnership with Anlitiks augments Excelra’s vision to use domain-led data science to empower innovation from discovery to market.
Rajagopalan elaborated, “Our vision is to be a technology-enabled disruptive force in generating rapid actionable insights for the Life Science industry using real-world data. Excelra’s focus areas dovetail perfectly with our growth strategy, making it the beginning of an exciting journey.” fiinews.com
